3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
Drug Therapy
4
Positron Emission Tomography Computed Tomography
2
Nivolumab
2
Magnetic Resonance Imaging
2
Immunohistochemistry
2
Diffusion Magnetic Resonance Imaging
2
Blood Specimen Collection
2
Biopsy
2
Tomography, X-Ray Computed
1
Surgical Procedures, Operative
1
Radiotherapy
1
Polymerase Chain Reaction
1
Neoadjuvant Therapy
1
Mass Spectrometry
1
Lymph Node Excision
1
In Situ Hybridization, Fluorescence
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Gastroscopy
1
Fluorouracil
1
Esophagectomy
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Cisplatin
1
Base Sequence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Esophageal Squamous Cell Carcinoma
×
Mass Spectrometry
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled